Journal of
Public Health and Epidemiology

  • Abbreviation: J. Public Health Epidemiol.
  • Language: English
  • ISSN: 2141-2316
  • DOI: 10.5897/JPHE
  • Start Year: 2009
  • Published Articles: 584

Full Length Research Paper

Factors associated with pulmonary tuberculosis treatment failure in Togo, 2015-2016

Tchalla Abalo Agballa Mébiny-Essoh1, Yanogo Pauline Kiswendsida1,2*, Adjoh Komi Séraphin3,4, Diallo Fadima1, Assane Hamadi1, Naba Mouchédou Abdelkarim1, Halatoko Wemboo Afiwa1, Sawadogo Bernard1, Antara Simon1, McKenzie Andre1, Sawadogo Mamadou1,2 and Meda Nicolas1,2
1West Africa Field Epidemiology Training Program, University Joseph KI-ZERBO, Burkina Faso. 2Faculty of Medicine, University Joseph Ki – Zerbo, Burkina Faso. 3Faculty of Health Sciences, University of Lomé, Togo. 4Sylvanus Olympio University Hospital, Lomé, Togo.
Email: [email protected]

  •  Received: 08 August 2019
  •  Accepted: 24 October 2019
  •  Published: 30 November 2019

References

Adamu AL, Gadanya MA, Abubakar IS (2017). High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infectious Diseases 170.
Crossref
 
Albuquerque MF, Leitão CC, Campelo AR (2001) [Prognostic factors for pulmonary tuberculosis outcome in Recife, Pernambuco, Brazil]. Revista Panamericana de Salud Pública 9:368-374.
Crossref
 
Anuwatnonthakate A, Limsomboon P, Nateniyom S (2008). Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS One 3:e3089.
Crossref
 
Baghaei P, Tabarsi P, Jabehdari S (2016). HIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study. International Journal of Mycobacteriology 5(1):S16-S17.
Crossref
 
Balabanova Y, Drobniewski F, Fedorin I (2006). The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respiratory Research 7:44.
Crossref
 
Bouti K, Aharmim M, Marc K (2013). Factors Influencing Sputum Conversion among Smear-Positive Pulmonary Tuberculosis Patients in Morocco. In: International Scholarly Research Notices.
Crossref
 
Cui Z, Lin M, Nie S, Lan R (2017). Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China. PLoS One 12:e0173976.
Crossref
 
Darré T, Tchaou M, Sonhaye L (2015). Analyse d'une série de 44 cas de tuberculose péritonéale diagnostiqués au laboratoire d'anatomie pathologique du CHU Tokoin de Lomé (1993-2014). Bulletin de la Société De Pathologie Exotique 108:324-327.
Crossref
 
Dye C, Scheele S, Dolin P (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. https://www.ncbi.nlm.nih.gov/pubmed/?term=Consensus+statement.+Global+burden+of+tuberculosis%3A+estimated+incidence%2C+prevalence%2C+and+mortality+by+country. Accessed 13 Jul 2019
 
Elmahalli AA, Abdel-Aziz BF (2007). Assessment of the implementation of DOTS strategy in two chest facilities in Alexandria, Egypt. Eastern Mediterranean Health Journal 13:1085-1097
Crossref
 
European Centre for Disease Control and Prevention, Word Health Organization (2018). European Region SURVEILLANCE REPORT. Tuberculosis surveillance and monitoring in Europe 2017. P. 162
 
Ferreira V, Brito C, Portela M (2011). DOTS in primary care units in the city of Rio de Janeiro, Southeastern Brazil. Revista de Saúde Pública 45:40-48.
Crossref
 
He GX, Wang HY, Borgdorff MW (2011). Multidrug-resistant tuberculosis, People's Republic of China, 2007-2009. Emerging Infectious Diseases 17:1831-1838.
Crossref
 
Heunis JC, Kigozi NG, Chikobvu P (2017). Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health 17:38.
Crossref
 
Hounkpati A, Adjoh K, Agli K (2008). Miliaire tuberculeuse : caractéristiques cliniques, thérapeutiques, et évolutives au CHU de Lome-Togo. /data/revues/07618425/00220HS1/27_2/
 
Juan G, Lloret T, Perez C (2006). Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain. International Journal of Tuberculosis and Lung Disease 10:215-221
 
Karo B, Hauer B, Hollo V (2015). Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Eurosurveillance 20:
Crossref
 
Kuaban C, Bame R, Mouangue L (2009). Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon. East African Medical Journal 86:219-225
Crossref
 
Lackey B, Seas C, Van der Stuyft P, Otero L (2015) Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru. PLoS One 10:e0128541.
Crossref
 
Lee J, Lee BJ, Yoon HI (2012). Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. International Journal of Tuberculosis and Lung Disease 16:1344-1348.
Crossref
 
Lema NA, Mbelele PM, Majigo M (2016). Risk factors associated with multidrug resistant tuberculosis among patients referred to Kibong'oto Infectious Disease Hospital in northern Tanzania. Tanzania Journal of Health Research 18:
 
Mlotshwa M, Abraham N, Beery M (2016). Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study. BMC Infectious Diseases 16:365.
Crossref
 
Muñoz-Sellart M, Cuevas LE, Tumato M (2010). Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. International Journal of Tuberculosis and Lung Disease 14:973-979
 
Nagu TJ, Aboud S, Mwiru R (2017). Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy. International Journal of Infectious Diseases 56:39-44.
Crossref
 
Nimagan S, Bopaka RG, Diallo MM (2015). [Predictive factors of TB treatment failure in Guinea Conakry]. Pan African Medical Journal 22:146.
Crossref
 
Ntshanga SP, Rustomjee R, Mabaso MLH (2009). Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 103:571-574.
Crossref
 
Pasipanodya JG, Gumbo T (2013). A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clinical Infectious Diseases 57:21-31.
Crossref
 
Pefura-Yone EW, Balkissou AD, Poka-Mayap V (2017). Development and validation of a prognostic score during tuberculosis treatment. BMC Infectious Diseases 17:251.
Crossref
 
Sawadogo B, Tint KS, Tshimanga M (2015). Risk factors for tuberculosis treatment failure among pulmonary tuberculosis patients in four health regions of Burkina Faso, 2009: case control study. Pan African Medical Journal 21:152.
Crossref
 
Scheelbeek PFD, Wirix AJG, Hatta M (2014). Risk factors for poor tuberculosis treatment outcomes in Makassar, Indonesia. Southeast Asian Journal of Tropical Medicine and Public Health 45:853-858
 
Segbedji KR, Djadou KE, Tchagbele O-B (2016). Tuberculose de l'enfant au Togo: aspects épidémiologiques, diagnostiques, thérapeutiques et évolutifs. Médecine et Santé Tropicales 26:318-322.
Crossref
 
Shrivastava SR, Shrivastava PS, Ramasamy J (2014) Fostering directly observed treatment in tuberculosis: a program manager's perspective. International Journal of Health Policy and Management 2:51-52.
Crossref
 
Shuldiner J, Leventhal A, Chemtob D, Mor Z (2014) Mortality of tuberculosis patients during treatment in Israel, 2000-2010. International Journal of Tuberculosis and Lung Disease 18:818-823.
Crossref
 
Siemion-Szcześniak I, Kuś J (2009) [Treatment outcomes in culture positive pulmonary tuberculosis]. Pneumonol Alergol Pol 77:11-22
 
Sinshaw Y, Alemu S, Fekadu A, Gizachew M (2017) Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study. BMC Infectious Diseases 17:132.
Crossref
 
Sisay S, Mengistu B, Erku W, Woldeyohannes D (2016) Ten years' experience of Directly Observed Treatment Short-course (DOTS) in Gambella Regional State, Ethiopia: An evaluation of tuberculosis control program. International Journal of Mycobacteriology 5(1):S117-S118.
Crossref
 
Takarinda KC, Sandy C, Masuka N (2017). Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberculosis Research and Treatment 2017:6232071.
Crossref
 
Tchaou M, Sonhaye L, Kotosso A, Adjenou K, Agoda-Koussema L, N'TIMON B, Amadou A, Djagnikpo O (2012). Aspects radiographiques des séquelles de la tuberculose chez les personnes vivant avec le VIH/SIDA à Lomé -Togo
 
Wang X-M, Yin S-H, Du J, Du ML, Wang PY, Wu J, Horbinski CM, Wu MJ, Zheng HQ, Xu XQ, Shu W (2017). Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model. Epidemiology and Infection 145:1805-1814.
Crossref
 
World Health Organization (2018). Global tuberculosis report 2018
 
Workicho A, Kassahun W, Alemseged F (2017). Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infection and Drug Resistance 10:91-96.
Crossref
 
Yee D, Valiquette C, Pelletier M (2003). Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. American Journal of Respiratory and Critical Care Medicine 167:1472-1477.
Crossref